Sarin KY, Artandi SE. Aging, graying and loss of melanocyte stem cells. Stem Cell Rev. 2007;3(3):212–7.

Article  CAS  PubMed  Google Scholar 

Redondo P, del Olmo J, García-Guzman M, Guembe L, Prósper F. Repigmentation of vitiligo by transplantation of autologous melanocyte cells cultured on amniotic membrane. Br J Dermatol. 2008y;158(5):1168–71.

Article  CAS  PubMed  Google Scholar 

Rosen CJ, Holick MF, Millard PS. Premature graying of hair is a risk marker for osteopenia. J Clin Endocrinol Metab. 1994;79(3):854–7.

CAS  PubMed  Google Scholar 

Penzi LR, Manatis-Lornell A, Saavedra A, Fisher D, Senna MM. Hair repigmentation associated with the use of brentuximab. JAAD Case Rep. 2017;3(6):563–5.

Article  PubMed  PubMed Central  Google Scholar 

Rongioletti F, Mugheddu C, Murgia S. Repigmentation and new growth of hairs after anti–interleukin-17 therapy with secukinumab for psoriasis. JAAD Case Rep. 2018;4(5):486–8.

Article  PubMed  PubMed Central  Google Scholar 

Rivera N, Boada A, Bielsa MI, Fernández-Figueras MT, Carcereny E, Moran MT, et al. Hair repigmentation during immunotherapy treatment with an anti-programmed cell death 1 and anti-programmed cell death ligand 1 agent for lung cancer. JAMA Dermatol. 2017;153(11):1162–5.

Article  PubMed  PubMed Central  Google Scholar 

Tintle SJ, Dabade TS, Kalish RA, Rosmarin DM. Repigmentation of hair following adalimumab therapy. Dermatol Online J. 2015. https://doi.org/10.5070/D3216027818.

Article  PubMed  Google Scholar 

Nishimura EK, Granter SR, Fisher DE. Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science. 2005;307(5710):720–4.

Article  CAS  PubMed  Google Scholar 

Tobin DJ. Aging of the hair follicle pigmentation system. Int J Trichol. 2009;1(2):83–93.

Article  Google Scholar 

Arck PC, Overall R, Spatz K, Liezman C, Handjiski B, Klapp BF, et al. Towards a “free radical theory of graying”: melanocyte apoptosis in the aging human hair follicle is an indicator of oxidative stress induced tissue damage. FASEB J Off Publ Fed Am Soc Exp Biol. 2006;20(9):1567–9.

CAS  Google Scholar 

Poon W, Vos P, Muresanu D, Vester J, von Wild K, Hömberg V, et al. Cerebrolysin Asian Pacific trial in acute brain injury and neurorecovery: design and methods. J Neurotrauma. 2015;32(8):571–80.

Article  PubMed  Google Scholar 

Zhang Y, Chopp M, Gang Zhang Z, Zhang Y, Zhang L, Lu M, et al. Prospective, randomized, blinded, and placebo-controlled study of Cerebrolysin dose-response effects on long-term functional outcomes in a rat model of mild traumatic brain injury. J Neurosurg. 2018;129(5):1295–304.

Article  CAS  PubMed  Google Scholar 

Plosker GL, Gauthier S. Cerebrolysin: a review of its use in dementia. Drugs Aging. 2009;26(11):893–915.

Article  CAS  PubMed  Google Scholar 

Bornstein NM, Guekht A, Vester J, Heiss WD, Gusev E, Hömberg V, et al. Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2018;39(4):629–40.

Google Scholar 

Nasiri J, Safavifar F. Effect of cerebrolysin on gross motor function of children with cerebral palsy: a clinical trial. Acta Neurol Belg. 2017;117(2):501–5.

Article  PubMed  Google Scholar 

Chen N, Yang M, Guo J, Zhou M, Zhu C, He L. Cerebrolysin for vascular dementia. Cochrane Database Syst Rev. 2013. https://doi.org/10.1002/14651858.CD008900.pub2.

Article  PubMed  PubMed Central  Google Scholar 

Park YK, Yi HJ, Choi KS, Lee YJ, Kim DW, Kwon SM. Cerebrolysin for the treatment of aneurysmal subarachnoid hemorrhage in adults: a retrospective chart review. Adv Ther. 2018;35(12):2224–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Keilhoff G, Lucas B, Pinkernelle J, Steiner M, Fansa H. Effects of cerebrolysin on motor-neuron-like NSC-34 cells. Exp Cell Res. 2014;327(2):234–55.

Article  CAS  PubMed  Google Scholar 

Lucas B, Pinkernelle J, Fansa H, Keilhoff G. Effects of cerebrolysin on rat Schwann cells in vitro. Acta Histochem. 2014;116(5):820–30.

Article  CAS  PubMed  Google Scholar 

Zhang L, Chopp M, Meier DH, Winter S, Wang L, Szalad A, et al. Sonic hedgehog signaling pathway mediates cerebrolysin-improved neurological function after stroke. Stroke. 2013;44(7):1965–72.

Article  CAS  PubMed  Google Scholar 

Vester JC, Buzoianu AD, Florian SI, Hömberg V, Kim SH, Lee TMC, et al. Cerebrolysin after moderate to severe traumatic brain injury: prospective meta-analysis of the CAPTAIN trial series. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2021. https://doi.org/10.1007/s10072-020-04974-6.

Article  Google Scholar 

Samir A, Nasef N, Fathy K, El-Gilany AH, Yahia S. Effect of cerebrolysin on neurodevelopmental outcome of high risk preterm infants: a randomized controlled trial. J Neonatal-Perinatal Med. 2021. https://doi.org/10.3233/NPM-200659.

Article  Google Scholar 

Kocaman SA, Çetin M, Durakoğlugil ME, Erdoğan T, Çanga A, Çiçek Y, et al. The degree of premature hair graying as an independent risk marker for coronary artery disease: a predictor of biological age rather than chronological age. Anadolu Kardiyol Derg AKD Anatol J Cardiol. 2012;12(6):457–63.

Google Scholar 

Kumar AB, Shamim H, Nagaraju U. Premature graying of hair: review with updates. Int J Trichol. 2018;10(5):198–203.

Article  Google Scholar 

Tobin DJ. Human hair pigmentation–biological aspects. Int J Cosmet Sci. 2008;30(4):233–57.

Article  CAS  PubMed  Google Scholar 

Mohanty S, Kumar A, Dhawan J, Sharma VK, Gupta S. Depletion of CD200+ hair follicle stem cells in human prematurely gray hair follicles. J Cutan Aesthetic Surg. 2013;6(2):90–2.

Article  Google Scholar 

Schallreuter KU, Salem MAEL, Holtz S, Panske A. Basic evidence for epidermal H2O2/ONOO(-)-mediated oxidation/nitration in segmental vitiligo is supported by repigmentation of skin and eyelashes after reduction of epidermal H2O2 with topical NB-UVB-activated pseudocatalase PC-KUS. FASEB J Off Publ Fed Am Soc Exp Biol. 2013;27(8):3113–22.

CAS  Google Scholar 

De Mazière AM, Muehlethaler K, van Donselaar E, Salvi S, Davoust J, Cerottini JC, et al. The melanocytic protein Melan-A/MART-1 has a subcellular localization distinct from typical melanosomal proteins. Traffic. 2002;3(9):678–93.

Article  PubMed  Google Scholar 

Hoashi T, Watabe H, Muller J, Yamaguchi Y, Vieira WD, Hearing VJ. MART-1 is required for the function of the melanosomal matrix protein PMEL17/GP100 and the maturation of melanosomes. J Biol Chem. 2005;280(14):14006–16.

Article  CAS  PubMed  Google Scholar 

Formichi P, Radi E, Battisti C, Di Maio G, Muresanu D, Federico A. Cerebrolysin administration reduces oxidative stress-induced apoptosis in lymphocytes from healthy individuals. J Cell Mol Med. 2012;16(11):2840–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ubhi K, Rockenstein E, Vazquez-Roque R, Mante M, Inglis C, Patrick C, et al. Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer’s disease. J Neurosci Res. 2013;91(2):167–77.

Article  CAS  PubMed  Google Scholar 

Vázquez-Roque RA, Ubhi K, Masliah E, Flores G. Chronic cerebrolysin administration attenuates neuronal abnormalities in the basolateral amygdala induced by neonatal ventral hippocampus lesion in the rat. Synapse. 2014;68(1):31–8.

Article  PubMed  Google Scholar 

Fonseca-Pereira D, Arroz-Madeira S, Rodrigues-Campos M, Barbosa IAM, Domingues RG, Bento T, et al. The neurotrophic factor receptor RET drives haematopoietic stem cell survival and function. Nature. 2014;514(7520):98–101.

Article  CAS  PubMed  Google Scholar 

Botchkarev VA, Botchkareva NV, Albers KM, Chen LH, Welker P, Paus R. A role for p75 neurotrophin receptor in the control of apoptosis-driven hair follicle regression. FASEB J Off Publ Fed Am Soc Exp Biol. 2000;14(13):1931–42.

CAS  Google Scholar 

Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46-110.

Article  PubMed  Google Scholar 

Onose G, Mureşanu DF, Ciurea AV, Daia Chendreanu C, Mihaescu AS, Mardare DC, et al. Neuroprotective and consequent neurorehabilitative clinical outcomes, in patients treated with the pleiotropic drug cerebrolysin. J Med Life. 2009;2(4):350–60.

CAS  PubMed  PubMed Central  Google Scholar 

Hartbauer M, Hutter-Paier B, Skofitsch G, Windisch M. Antiapoptotic effects of the peptidergic drug cerebrolysin on primary cultures of embryonic chick cortical neurons. J Neural Transm. 2001;108(4):459–73.

Article  CAS  PubMed  Google Scholar 

Zhang C, Chopp M, Cui Y, Wang L, Zhang R, Zhang L, et al. Cerebrolysin enhances neurogenesis in the ischemic brain and improves functional outcome after stroke. J Neurosci Res. 2010;88(15):3275–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hutter-Paier B, Steiner E, Windisch M. Cerebrolysin protects isolated cortical neurons from neurodegeneration after brief histotoxic hypoxia. J Neural Transm Suppl. 1998;53:351–61.